Vaccinex Stock Forecast, Price & News

Vaccinex (NASDAQ:VCNX) Frequently Asked Questions

How has Vaccinex's stock price been impacted by COVID-19 (Coronavirus)?

Vaccinex's stock was trading at $4.17 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, VCNX shares have decreased by 59.2% and is now trading at $1.70.
View which stocks have been most impacted by COVID-19.

When is Vaccinex's next earnings date?

Vaccinex is scheduled to release its next quarterly earnings announcement on Monday, February 14th 2022.
View our earnings forecast for Vaccinex.

How were Vaccinex's earnings last quarter?

Vaccinex, Inc. (NASDAQ:VCNX) issued its earnings results on Monday, November, 8th. The company reported ($0.17) EPS for the quarter, beating the Zacks' consensus estimate of ($0.29) by $0.12.
View Vaccinex's earnings history.

Who are Vaccinex's key executives?

Vaccinex's management team includes the following people:

• Maurice Zauderer, President, Chief Executive Officer & Director
• Elizabeth Evans, Chief Operating Officer
• Scott E. Royer, Chief Financial & Accounting Officer
• Ernie Smith, Chief Scientific Officer & Senior VP-Research
• John E. Leonard, Senior Vice President-Development

Who are some of Vaccinex's key competitors?

Some companies that are related to Vaccinex include Annovis Bio (ANVS), CM Life Sciences III (CMLT), Immunome (IMNM), Athenex (ATNX), Alzamend Neuro (ALZN), Frequency Therapeutics (FREQ), Mustang Bio (MBIO), Millendo Therapeutics (MLND), Infinity Pharmaceuticals (INFI), CorMedix (CRMD), Seelos Therapeutics (SEEL), Inozyme Pharma (INZY), 180 Life Sciences (ATNF), TFF Pharmaceuticals (TFFP) and Decibel Therapeutics (DBTX).
View all of VCNX's competitors.

What other stocks do shareholders of Vaccinex own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Vaccinex investors own include VBI Vaccines (VBIV), OPKO Health (OPK), Aldeyra Therapeutics (ALDX), Sorrento Therapeutics (SRNE), Cerecor (CERC), Exelixis (EXEL), Pfizer (PFE), AVEO Pharmaceuticals (AVEO), Heat Biologics (HTBX) and SCYNEXIS (SCYX).

When did Vaccinex IPO?

(VCNX) raised $45 million in an initial public offering on Thursday, August 9th 2018. The company issued 3,300,000 shares at a price of $12.00-$15.00 per share. Oppenheimer and BTIG acted as the underwriters for the IPO and Ladenburg Thalmann was co-manager.

What is Vaccinex's stock symbol?

Vaccinex trades on the NASDAQ under the ticker symbol "VCNX."

Who are Vaccinex's major shareholders?

Vaccinex's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Telemetry Investments L.L.C. (0.43%), Geode Capital Management LLC (0.42%), Natixis (0.10%), Oppenheimer & Co. Inc. (0.10%) and HAP Trading LLC (0.00%). Company insiders that own Vaccinex stock include Albert Friedberg and Maurice Zauderer.
View institutional ownership trends for Vaccinex.

Which institutional investors are selling Vaccinex stock?

VCNX stock was sold by a variety of institutional investors in the last quarter, including Oppenheimer & Co. Inc..
View insider buying and selling activity for Vaccinex or view top insider-selling stocks.

Which institutional investors are buying Vaccinex stock?

VCNX stock was bought by a variety of institutional investors in the last quarter, including Natixis, Geode Capital Management LLC, Telemetry Investments L.L.C., and HAP Trading LLC. Company insiders that have bought Vaccinex stock in the last two years include Albert Friedberg, and Maurice Zauderer.
View insider buying and selling activity for Vaccinex or or view top insider-buying stocks.

How do I buy shares of Vaccinex?

Shares of VCNX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Vaccinex's stock price today?

One share of VCNX stock can currently be purchased for approximately $1.70.

How much money does Vaccinex make?

Vaccinex has a market capitalization of $52.36 million and generates $630 thousand in revenue each year.

How many employees does Vaccinex have?

Vaccinex employs 40 workers across the globe.

What is Vaccinex's official website?

The official website for Vaccinex is www.vaccinex.com.

Where are Vaccinex's headquarters?

Vaccinex is headquartered at 1895 MOUNT HOPE AVENUE, ROCHESTER NY, 14620.

How can I contact Vaccinex?

Vaccinex's mailing address is 1895 MOUNT HOPE AVENUE, ROCHESTER NY, 14620. The company can be reached via phone at (585) 271-2700, via email at [email protected], or via fax at 585-271-2765.